Purification method for human plasma kallikrein by a new affinity chromatography

被引:0
|
作者
Tada, M
Wanaka, K
Okamoto, S
Okamoto, U
Nakaya, Y
Horie, N
Hijikata-Okunomiya, A
Tsuda, Y
Okada, Y [1 ]
机构
[1] Kobe Gakuin Univ, Fac Pharmaceut Sci, Nishi Ku, Kobe, Hyogo 65121, Japan
[2] Kobe Res Projects Thrombosis & Haemostasis, Tarumi Ku, Kobe, Hyogo 655, Japan
[3] Mukogawa Womens Univ, Sch Human Environm Sci, Dept Food Sci & Nutr, Nishinomiya, Hyogo 663, Japan
[4] Kobe Univ, Sch Med, Fac Hlth Sci, Suma Ku, Kobe, Hyogo 65401, Japan
关键词
plasma kallikrein; affinity chromatography; synthetic inhibitor; simple purification;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We synthesized a new affinity gel (PKSI-Toyopearl) using a selective synthetic inhibitor of plasma kallikrein (PKSI-527) as an affinity ligand, and employed it for the rapid purification of plasma kallikrein from human plasma. Human plasma activated with kaolin after acid treatment was applied to a PKSI-Toyopearl column. Adsorbed protein was eluted with 50 mM glycine-hydrochloric acid buffer (pH 3.0). Plasma kallikrein was purified 181-fold with a yield of 85% from the kaolin-activated plasma. Further purification was performed by chromatography on a DEAE-Toyopearl 650M column. Plasma kallikrein,vas finally purified 1720-fold with a 63% yield by these procedures. On sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, a band was observed at approximately 88 kDa. These findings indicate that PKSI-Toyopearl is a valuable tool for the purification of plasma kallikrein from human plasma.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条